2202: GLP‑1 Gold Rush: MedPal AI’s CEO on Turning a £45k Deal into a £100bn Opportunity
Update: 2025-10-02
Description
MedPal AI has just acquired a licensed online pharmacy and raised £550k to support its next big move: entering the fast-growing GLP‑1 weight-loss market. With drugs like Ozempic and Mounjaro in high demand — and online prescribing facing tighter regulation — MedPal is combining AI health coaching with compliant, NHS-linked pharmacy fulfilment. CEO Jason Drummond joins Vox Markets to break down the deal, the strategy, and what’s next.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
